These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 36243961)

  • 21. Radiolabeled absorption, distribution, metabolism, and excretion studies in drug development: why, when, and how?
    Penner N; Xu L; Prakash C
    Chem Res Toxicol; 2012 Mar; 25(3):513-31. PubMed ID: 22309195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics in drug development and assessment.
    Wishart DS
    Drug Metab Rev; 2005; 37(2):279-310. PubMed ID: 15931766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of new drug classification terms in textual resources.
    Kolárik C; Hofmann-Apitius M; Zimmermann M; Fluck J
    Bioinformatics; 2007 Jul; 23(13):i264-72. PubMed ID: 17646305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
    Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
    Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: Application of the Extended Clearance Classification System.
    El-Kattan AF; Varma MV; Steyn SJ; Scott DO; Maurer TS; Bergman A
    Pharm Res; 2016 Dec; 33(12):3021-3030. PubMed ID: 27620173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets.
    Wenzel J; Matter H; Schmidt F
    J Chem Inf Model; 2019 Mar; 59(3):1253-1268. PubMed ID: 30615828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge-based approaches in the design and selection of compound libraries for drug discovery.
    Viswanadhan VN; Balan C; Hulme C; Cheetham JC; Sun Y
    Curr Opin Drug Discov Devel; 2002 May; 5(3):400-6. PubMed ID: 12058615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting ADME properties and side effects: the BioPrint approach.
    Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs.
    Migliorati JM; Liu S; Liu A; Gogate A; Nair S; Bahal R; Rasmussen TP; Manautou JE; Zhong XB
    Drug Metab Dispos; 2022 Jun; 50(6):888-897. PubMed ID: 35221287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADME-AP: a database of ADME associated proteins.
    Sun LZ; Ji ZL; Chen X; Wang JF; Chen YZ
    Bioinformatics; 2002 Dec; 18(12):1699-700. PubMed ID: 12490461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases.
    Li P; Chen J; Wang J; Zhou W; Wang X; Li B; Tao W; Wang W; Wang Y; Yang L
    J Ethnopharmacol; 2014; 151(1):93-107. PubMed ID: 23850710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical assessment of AI in drug discovery.
    Walters WP; Barzilay R
    Expert Opin Drug Discov; 2021 Sep; 16(9):937-947. PubMed ID: 33870801
    [No Abstract]   [Full Text] [Related]  

  • 35. [Artificial Intelligence in Drug Discovery].
    Fujiwara T; Kamada M; Okuno Y
    Gan To Kagaku Ryoho; 2018 Apr; 45(4):593-596. PubMed ID: 29650810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification of drug molecules considering their IC50 values using mixed-integer linear programming based hyper-boxes method.
    Armutlu P; Ozdemir ME; Uney-Yuksektepe F; Kavakli IH; Turkay M
    BMC Bioinformatics; 2008 Oct; 9():411. PubMed ID: 18834515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Success stories of AI in drug discovery - where do things stand?
    Mak KK; Balijepalli MK; Pichika MR
    Expert Opin Drug Discov; 2022 Jan; 17(1):79-92. PubMed ID: 34553659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an ADME and drug-drug interactions knowledge database for the acceleration of drug discovery and development.
    Petitet F; Barberan O; Dubus E; Ijjaali I; Donlan M; Ollivier S; Michel A
    Expert Opin Drug Discov; 2006 Dec; 1(7):737-51. PubMed ID: 23495997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADME-Space: a new tool for medicinal chemists to explore ADME properties.
    Bocci G; Carosati E; Vayer P; Arrault A; Lozano S; Cruciani G
    Sci Rep; 2017 Jul; 7(1):6359. PubMed ID: 28743970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TarNet: An Evidence-Based Database for Natural Medicine Research.
    Hu R; Ren G; Sun G; Sun X
    PLoS One; 2016; 11(6):e0157222. PubMed ID: 27337171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.